82 FR 20606 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 84 (May 3, 2017)

Page Range		20606-20606
FR Document		2017-08946

Federal Register, Volume 82 Issue 84 (Wednesday, May 3, 2017)

[Federal Register Volume 82, Number 84 (Wednesday, May 3, 2017)]
[Notices]
[Page 20606]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-08946]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: June 1, 2017.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Room 3F40, 5601 Fishers 
Lane, Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Robert C. Unfer, Ph.D., Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers 
Lane, Room 3F40 MSC 9823, Rockville, MD 20892-9823, 240-669-5035, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: April 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-08946 Filed 5-2-17; 8:45 am]
 BILLING CODE 4140-01-P

20606 Federal Register / Vol. 82, No. 84 / Wednesday, May 3, 2017 / Notices

1. Piedmont Bancorp, Inc., Norcross, Trust Company, LLC. Plimoth Dated: April 27, 2017.
Georgia; to merge with Mountain Valley Massachusetts, and thereby engage in Frank Hearl,
Bancshares, Inc., and thereby indirectly trust company activities pursuant to Chief of Staff, National Institute for
acquire, Mountain Valley Community section 225.28(b)(5). Occupational Safety and Health, Centers for
Bank, both of Cleveland, Georgia. In addition, Plimoth has applied to Disease Control and Prevention.
B. Federal Reserve Bank of Chicago acquire certain assets and assume [FR Doc. 2017–08887 Filed 5–2–17; 8:45 am]
(Colette A. Fried, Assistant Vice certain liabilities from Savings Institute BILLING CODE 4163–19–P
President), 230 South LaSalle Street, Bank and Trust Company, Willimantic,
Chicago, Illinois 60690–1414: Connecticut.
1. West Town Bancorp, Inc., Raleigh,
Board of Governors of the Federal Reserve DEPARTMENT OF HEALTH AND
North Carolina; to acquire 100 percent
System, April 27, 2017. HUMAN SERVICES
of the outstanding voting shares of
Yao-Chin Chao,
Sound Banking Company, Morehead National Institutes of Health
City, North Carolina. Assistant Secretary of the Board.
[FR Doc. 2017–08854 Filed 5–2–17; 8:45 am]
Board of Governors of the Federal Reserve National Institute of Allergy and
BILLING CODE 6210–01–P
System, April 27, 2017. Infectious Diseases; Notice of Closed
Yao-Chin Chao, Meeting
Assistant Secretary of the Board. DEPARTMENT OF HEALTH AND
[FR Doc. 2017–08890 Filed 5–2–17; 8:45 am] HUMAN SERVICES Pursuant to section 10(d) of the
BILLING CODE 6210–01–P Federal Advisory Committee Act, as
Centers for Disease Control and amended (5 U.S.C. App.), notice is
Prevention hereby given of the following meeting.
FEDERAL RESERVE SYSTEM The meeting will be closed to the
Notice of Proposals To Engage in or [CDC–2015–0021; Docket Number NIOSH– public in accordance with the
153–C] provisions set forth in sections
To Acquire Companies Engaged in
Permissible Nonbanking Activities 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Issuance of Final Guidance
as amended. The contract proposals and
The companies listed in this notice Publications
the discussions could disclose
have given notice under section 4 of the AGENCY: National Institute for confidential trade secrets or commercial
Bank Holding Company Act (12 U.S.C. Occupational Safety and Health property such as patentable material,
1843) (BHC Act) and Regulation Y, (12 (NIOSH) of the Centers for Disease and personal information concerning
CFR part 225) to engage de novo, or to Control and Prevention (CDC), individuals associated with the contract
acquire or control voting securities or Department of Health and Human proposals, the disclosure of which
assets of a company, including the Services (HHS). would constitute a clearly unwarranted
companies listed below, that engages
ACTION: Notice of issuance of final invasion of personal privacy.
either directly or through a subsidiary or
other company, in a nonbanking activity guidance publications. Name of Committee: National Institute of
that is listed in § 225.28 of Regulation Y Allergy and Infectious Diseases Special
SUMMARY: NIOSH announces the Emphasis Panel; NIAID Peer Review Meeting.
(12 CFR 225.28) or that the Board has
availability of the following final 5 Skin Date: June 1, 2017.
determined by Order to be closely
Notation Profiles: Acrylic acid [CAS No. Time: 2:00 p.m. to 5:00 p.m.
related to banking and permissible for
79–01–7], Dichlorvos [CAS No. 62–73– Agenda: To review and evaluate contract
bank holding companies. Unless
7], Morpholine [CAS No. 110–91–8], proposals.
otherwise noted, these activities will be
Ethyl p-nitrophenyl Place: National Institutes of Health, Room
conducted throughout the United States.
Each notice is available for inspection phenylphosphorothioate (EPN) [CAS 3F40, 5601 Fishers Lane, Rockville, MD
at the Federal Reserve Bank indicated. No. 2104–64–5], Dioxathion [CAS No. 20892 (Telephone Conference Call).
The notice also will be available for 78–34–2]. Contact Person: Robert C. Unfer, Ph.D.,
inspection at the offices of the Board of DATES: The final Skin Notation Profiles Scientific Review Officer, Scientific Review
Governors. Interested persons may documents were published on April 10, Program, DEA/NIAID/NIH/DHHS, 5601
express their views in writing on the 2017. Fishers Lane, Room 3F40 MSC 9823,
question whether the proposal complies Rockville, MD 20892–9823, 240–669–5035,
ADDRESSES: These documents may be
with the standards of section 4 of the unferrc@nih.gov.
obtained at the following link: http://
BHC Act. www.cdc.gov/niosh/topics/skin/skin- (Catalogue of Federal Domestic Assistance
Unless otherwise noted, comments notation_profiles.html. Program Nos. 93.855, Allergy, Immunology,
regarding the applications must be and Transplantation Research; 93.856,
FOR FURTHER INFORMATION CONTACT: Microbiology and Infectious Diseases
received at the Reserve Bank indicated
or the offices of the Board of Governors Naomi Hudson, Dr. P.H., NIOSH, Research, National Institutes of Health, HHS)
not later than May 17, 2017. Education and Information Division
(EID), Robert A. Taft Laboratories, 1090 Dated: April 28, 2017.
A. Federal Reserve Bank of Boston
Tusculum Ave. MS–C32, Cincinnati, Natasha M. Copeland,
(Prabal Chakrabarti, Senior Vice
President) 600 Atlantic Avenue, Boston, OH 45226, email: iuz8@cdc.gov. Program Analyst, Office of Federal Advisory
nlaroche on DSK30NT082PROD with NOTICES

Massachusetts 02210–2204. Comments SUPPLEMENTARY INFORMATION: On May 1, Committee Policy.
can also be sent electronically to 2015, NIOSH published a request for [FR Doc. 2017–08946 Filed 5–2–17; 8:45 am]
BOS.SRC.Applications.Comments@ public review in the Federal Register BILLING CODE 4140–01–P
bos.frb.org: [80 FR 24932] on skin notation profiles
1. Narragansett Financial Corp., and technical documents. All comments
Swansea, Massachusetts; to retain 80 received were reviewed and accepted
percent of the voting shares of Plimoth where appropriate.

VerDate Sep<11>2014 14:29 May 02, 2017 Jkt 241001 PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 E:\FR\FM\03MYN1.SGM 03MYN1

Document Created: 2018-11-08 08:36:17
Document Modified: 2018-11-08 08:36:17

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 1, 2017.
FR Citation		82 FR 20606

82 FR 20606 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 84 (May 3, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health